• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medication during breastfeeding and pregnancy is challenging for women with the condition. Little data exists about how long-term exposure to these medications can affect the fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge that more high quality research is needed.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication must weigh the benefits of taking it versus the risks to the baby. Doctors don't have enough data to give clear advice however they can provide information about risks and benefits to aid pregnant women in making an informed decision.

A study published in Molecular Psychiatry found that women who were taking ADHD medications during their early pregnancy did not have a significantly higher risk of fetal cardiac malformations or major structural birth defects. Researchers used a large population-based case control study to compare the incidence of major structural defects in infants who were born to mothers who were taking stimulants during pregnancy. Clinical geneticists and pediatric cardiologists looked over the counter adhd medication uk the cases to ensure correct classification of the cases and to reduce the possibility of bias.

The study of the researchers was not without limitations. In particular, they were unable to separate the effects of the medication from the disorder that is underlying. This limitation makes it difficult remedies for adhd in adults researchers to determine if the few associations observed between the groups that were exposed to the use of medication or if they were caused by co-morbidities. Researchers also did not look at long-term outcomes for the offspring.

The study did reveal that babies whose mothers had taken ADHD medications during pregnancy were at slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or had cut back on their medications prior to or during pregnancy. The reason for this was central nervous system-related disorders and the increased risk for admission did not appear to be affected by the type of stimulant medications were taken during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having caesarean sections or one whose baby scored low on the Apgar scale (less than 7). These increases appeared to be unrelated to the type of medication used during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during early pregnancy may be offset by the greater benefits for both mother and child of continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, where possible, assist them in developing strategies for improving their coping skills that may minimize the impact of her disorder on her daily life and relationships.

Medication Interactions

More and more doctors are faced with the decision of whether to continue treatment or stop during pregnancy as more women are diagnosed with ADHD. The majority of these decisions are made in the absence of clear and authoritative evidence regardless, so doctors have to weigh their experience about their experiences, the experiences of other doctors, and what research suggests about the subject and their best judgment for each individual patient.

The issue of potential risks to infants is particularly tricky. Many studies on this topic are based on observations rather than controlled research and their conclusions are often contradictory. Additionally, the majority of studies limit their analysis to live births, which could underestimate severe teratogenic effects that lead to abortion or termination of the pregnancy. The study discussed in the journal club addresses these limitations by analyzing both the data from deceased and live births.

Conclusion Some studies have revealed a positive correlation between ADHD medications and certain birth defects However, other studies haven't established a link. Most studies show a neutral, or even somewhat negative, impact. In each case an in-depth study of the risks and benefits must be performed.

For a lot of women with ADHD who suffer from ADHD, the decision to stop medication can be difficult, if not impossible. In a recent article in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of loneliness, and family conflict for these patients. A decrease in medication could also affect the ability to safely drive and complete work-related tasks, which are crucial aspects of normal life for those suffering from ADHD.

She suggests that women who aren't sure whether to take the medication or discontinue it due to pregnancy, educate their family members, coworkers and their friends about the condition, the effects on daily functioning, and the benefits of continuing the current treatment regimen. Educating them can also aid in ensuring that the woman feels supported in her struggle with her decision. It is important to remember that certain medications can be absorbed through the placenta so if a woman decides to discontinue her ADHD medication during pregnancy and breastfeeding, she should be aware that traces of the drug could be transferred to the child.

Risk of Birth Defects

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns about the effects that the medications could have on the fetuses. A study that was published in the journal Molecular Psychiatry adds to the existing information on this topic. With two massive data sets, researchers were able to examine more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. While the overall risk remains low, the scientists discovered that the first-trimester exposure to ADHD medicines was associated with a slightly higher rate of certain heart defects, like ventriculo-septal defects (VSD).

The authors of the study found no connection between early use of medication and congenital abnormalities like facial clefting, or club foot. The results are in the same vein as previous studies which showed a small, but significant increase in cardiac malformations for women who began taking ADHD medication before pregnancy. The risk was higher in the later part of pregnancy, when many women decide to stop taking their ADHD medications.

Women who used ADHD medications in the first trimester of pregnancy were also more likely to undergo caesarean section, low Apgar score following delivery, and a baby that required breathing assistance during birth. However the authors of the study were not able to eliminate bias due to selection by restricting the study to women who did not have any other medical issues that could have contributed to these findings.

The researchers hope their study will help inform the clinical decisions of doctors who see pregnant women. They suggest that although a discussion of the benefits and risks is important however, the decision to stop or maintain medication must be based on each woman's needs and the severity of her ADHD symptoms.

The authors also caution that even though stopping the medication is an option, it isn't a recommended practice because of the high incidence of depression and other mental health issues for women who are expecting or postpartum. Furthermore, research suggests that women who decide to stop their medications are more likely to experience difficulties getting used to life without them after the baby's arrival.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women suffering from ADHD are often faced with a number of difficulties when they must deal with their symptoms, go to doctor appointments, prepare for the birth of a baby and adjust to a new routine. Therefore, many women decide to continue taking their ADHD medication throughout the pregnancy.

The majority of stimulant medicines pass through breast milk in very small amounts, therefore the risk for nursing infant is very low. The amount of exposure to medications can i get adhd medication without a diagnosis vary depending upon the dosage the medication is administered, its frequency and the time of day. In addition, various medications are introduced into the baby's system via the gastrointestinal tract or through breast milk. The impact of these medications on a newborn's health is not completely comprehended.

Some doctors may stop taking stimulant medication during a woman's pregnancy due to the absence of research. This is a complicated decision for the patient, who must weigh the benefits of keeping her medication for adhd and depression against the possible risks to the fetus. Until more information becomes available, doctors can inquire about pregnant patients if they have an background of ADHD or if they are planning to take medication in the perinatal period.

A growing number of studies have shown that most popular adhd medication (mouse click the following website page) women can safely continue their ADHD medication while they are pregnant and nursing. As a result, many patients choose to do so and in consultation with their physician, they have discovered that the benefits of maintaining their current medication far exceed any risk.

Women with ADHD who plan to breastfeed should seek advice from an expert psychiatrist prior to becoming pregnant. They should review their medications with their prescriber and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant women suffering from ADHD recognize the signs and underlying disorder. They should also learn about treatment options and build strategies for coping. This should involve a multidisciplinary approach with the GP doctors, obstetricians and psychiatrists. Pregnancy counseling should include a discussion of a treatment plan for the mother and child, as well as monitoring for signs of deterioration and, if necessary modifications to the medication regime.